Literature DB >> 23920875

Standardizing drug adverse event reporting data.

Liwei Wang1, Guoqian Jiang, Dingcheng Li, Hongfang Liu.   

Abstract

Normalizing data in the Adverse Event Reporting System (AERS), an FDA database, would improve the mining capacity of AERS for drug safety signal detection. In this study, we aim to normalize AERS and build a publicly available normalized Adverse drug events (ADE) data source.he drug information in AERS is normalized to RxNorm, a standard terminology source for medication. Drug class information is then obtained from the National Drug File - Reference Terminology (NDF-RT). Adverse drug events (ADE) are aggregated through mapping with the PT (Preferred Term) and SOC (System Organ Class) codes of MedDRA. Our study yields an aggregated knowledge-enhanced AERS data mining set (AERS-DM). The AERS-DM could provide more perspectives to mine AERS database for drug safety signal detection and could be used by research community in the data mining field.

Entities:  

Mesh:

Year:  2013        PMID: 23920875

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  Using description logics to evaluate the consistency of drug-class membership relations in NDF-RT.

Authors:  Rainer Winnenburg; Jonathan M Mortensen; Olivier Bodenreider
Journal:  J Biomed Semantics       Date:  2015-03-28

2.  Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets.

Authors:  Mateusz Maciejewski; Eugen Lounkine; Steven Whitebread; Pierre Farmer; William DuMouchel; Brian K Shoichet; Laszlo Urban
Journal:  Elife       Date:  2017-08-08       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.